You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
The new oral anti-coagulants and the phase 3 clinical trials - a systematic review of the literature
|
|---|---|
| Published in |
Thrombosis Journal, September 2013
|
| DOI | 10.1186/1477-9560-11-18 |
| Pubmed ID | |
| Authors |
Faryal Tahir, Haris Riaz, Talha Riaz, Maaz B Badshah, Irbaz B Riaz, Ameer Hamza, Hafsa Mohiuddin |
| Abstract |
Anticoagulation with vitamin K antagonists such as warfarin has historically been used for the long term management of patients with thromboembolic disease. However, these agents have a slow onset of action which requires bridging therapy with heparin and its analogues, which are available only in parenteral route. To overcome these limitations, new oral anticoagulants such as factor Xa inhibitors and direct thrombin inhibitors have been developed. The aim of this article is to systematically review the phase 3 clinical trials of new oral anticoagulants in common medical conditions. |
Mendeley readers
The data shown below were compiled from readership statistics for 153 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 2 | 1% |
| Denmark | 2 | 1% |
| Colombia | 1 | <1% |
| France | 1 | <1% |
| Netherlands | 1 | <1% |
| Chile | 1 | <1% |
| Slovenia | 1 | <1% |
| Unknown | 144 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 30 | 20% |
| Researcher | 23 | 15% |
| Student > Bachelor | 21 | 14% |
| Student > Postgraduate | 16 | 10% |
| Other | 16 | 10% |
| Other | 30 | 20% |
| Unknown | 17 | 11% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 89 | 58% |
| Pharmacology, Toxicology and Pharmaceutical Science | 14 | 9% |
| Agricultural and Biological Sciences | 5 | 3% |
| Economics, Econometrics and Finance | 4 | 3% |
| Arts and Humanities | 3 | 2% |
| Other | 12 | 8% |
| Unknown | 26 | 17% |
Attention Score in Context
This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 April 2021.
All research outputs
#2,427,561
of 25,371,288 outputs
Outputs from Thrombosis Journal
#30
of 406 outputs
Outputs of similar age
#20,595
of 208,959 outputs
Outputs of similar age from Thrombosis Journal
#2
of 4 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 406 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.0. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 208,959 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.